Former medical officer of HHS, dr. Vanila Singh, is hopeful that the COVID vaccine process will improve.
According to the latest data from the Centers for Disease Control and Prevention, more than 92 million COVID-19 vaccine doses were administered in the United States on Monday.
There are currently three vaccines approved by the CDC and the Food and Drug Administration for emergency use, manufactured by Pfizer and BioNTech, Moderna and Johnson & Johnson.
| Ticker | Safety | Last | Alter | Alter% |
|---|---|---|---|---|
| PFE | PFIZER INC. | 34.32 | -0.05 | -0.15% |
| BNTX | BIONTECH SE | 90.29 | -5.91 | -6.14% |
| MRNA | MODERNA, INC. | 123.47 | -8.72 | -6.60% |
| JNJ | JOHNSON & JOHNSON | 157.47 | +1.35 | + 0.86% |
Here’s a FOX Business summary of the profits each company’s vaccine is expected to bring in:
DEMOCRATS ‘VALID LIGHTING BY THE NUMBERS IS DISSOLUTION
Pfizer and BioNTech
Pfizer and BioNTech’s Comirnaty vaccine, the first to receive an FDA emergency authorization in December after being 95% effective, is currently responsible for more than 46.8 million of the total vaccine doses administered in the United States, according to the CDC.
According to Pfizer’s latest earnings report, Comirnaty’s profits are split 50-50 with BioNTech. The companies expect the vaccine to yield about $ 15 billion by 2021. Pfizer and BioNTech plan to deliver up to 1.3 billion doses of the vaccine worldwide by the end of 2021. The vaccine, which requires two doses, costs $ 39 in the United States. States and £ 28 in the EU.
Vials with Pfizer-BioNTech COVID-19 vaccines can be injected on Sunday, December 20, 2020 at the medical staff at Ichilov Hospital in Tel Aviv, Israel. (AP Photo / Ariel Schalit)
Following Comirnaty’s approval, the United States agreed to pay the companies $ 1.95 billion after receiving the first 100 million doses. The agreement also enabled the federal government to purchase an additional dose of $ 50 million. Later that month, Pfizer, BioNTech and the federal government reached a second agreement for another 100 million doses for the same price of $ 1.95 billion. Under the second agreement, the companies will deliver at least 70 million of the additional doses by 30 June, with the remaining 30 million doses to be delivered no later than 31 July. The government also has the option to obtain up to 400 million extra. doses.
Pfizer and BioNTech also announced in November an agreement with the European Commission to distribute 200 million doses of the vaccine among the 27 member states of the European Union, with the option of requesting an additional 100 million doses. The European Commission made the request in December, Pfizer said.
Last month, Pfizer said the European Commission had reached a second agreement for an additional dose of 200 million, of which 75 million will be provided in the second quarter of 2021. The total number of doses to be delivered to EU countries by the end. of 2021 is now 500 million, with the potential to increase to 600 million based on the option granted in the new agreement.
MARRIOTT PAYING EMPLOYEES TO GET COVID-19 VACCINE
Modern
Moderna’s mRNA-1273 vaccine, the second approved by the FDA for emergency use after being 94.5% effective, is responsible for more than 44.9 million of the total vaccine doses administered in the United States, according to the CDC .
The company noted in its fourth-quarter earnings report that it expects $ 18.4 billion in expected product sales related to advanced purchased agreements for its vaccine. Moderna remains on track to deliver the first 100 million doses in the first quarter of 2021 and the second order of 100 million doses in May 2021. The company aims to build up supply to 1 billion doses in 2021 and 1.4 billion doses in 2022.
Boxes of the Modern COVID-19 vaccine are ready to be shipped to the McKesson Distribution Center in Olive Branch, Miss., Sunday, December 20, 2020. (AP Photo / Paul Sancya, Pool)
Moderna has reached an agreement with the United States for 300 million doses, with the option to purchase another 200 million doses. In addition, the company has reached agreements with the European Union (310 million doses with the option to purchase another 150 million doses by 2022), Japan (50 million doses), Canada (44 million doses), the Republic of Korea (40 million doses) ), the United Kingdom (17 million doses), Switzerland (13.5 million doses), Colombia (10 million doses), Israel (6 million doses) and Taiwan (5 million doses).
Modern charges $ 30 for required two shots in US and $ 36 in EU
GET FOX BUSINESS ON THE GO by clicking here
The Johnson & Johnson vaccine, manufactured by its pharmaceutical subsidiary Janssen, received an emergency use authorization on February 27 and an official stamp of approval from the CDC a day later.
According to an FDA analysis, the Janssen vaccine was approximately 67% effective in preventing moderate to severe cases within 14 days of administration and 66% effective in severe to critical cases after 28 days. In addition, the vaccine was approximately 77% effective in preventing severe or critical COVID-19 occurring at least 14 days after vaccination, and 85% effective in preventing severe or critical COVID-19 at least 28 days after vaccination.
Boxes containing the Johnson & Johnson COVID-19 vaccine are placed next to vials at the National Jewish Hospital pharmacy for distribution early Saturday, March 6, 2021, east of Denver. Volunteers worked with National Jewis nurses and physicians
The company is currently delivering its initial stock of 3.9 million doses of vaccine to state health departments, pharmacies, federally qualified health centers and community vaccination centers across the country. Johnson & Johnson expects to deliver enough single-shot vaccines by the end of March to vaccinate more than 20 million Americans, and by June 100 million single-shot vaccines. Unlike the other two available vaccines, the Janssen vaccine requires a single dose.
The company is on track to produce 1 billion doses for global distribution by the end of 2021, which would yield up to $ 10 billion. In August, Johnson & Johnson reached an agreement of more than $ 1 billion with the United States for 100 million doses of its vaccine, with the option to purchase an additional dose of 200 million, for $ 10 per shot. In addition, Johnson & Johnson has reached an agreement with the EU for up to 400 million doses.
CLICK HERE TO READ MORE ABOUT FOX BUSINESS
According to Johns Hopkins University, the United States has surpassed 29 million COVID-19 cases since the pandemic began in March 2020, with more than 525,000 related deaths.